Revvity Inc Stock Price Declines Following Mixed Earnings and Adjusted Guidance
Revvity Inc, a health science solutions provider, has experienced a decline in its stock price over the past few days. The company’s shares have decreased in value, with investors currently purchasing each share for approximately $90, a decrease of around $4 from the previous day’s closing price.
Second-Quarter Earnings and Adjusted Guidance
Revvity Inc posted mixed second-quarter earnings, which contributed to the decline in stock price. The company has also trimmed its adjusted financial guidance for the full year, citing challenges in its business operations.
Analyst Price Targets and Market Reaction
Analysts have lowered their price targets for Revvity Inc, citing challenges in the immunodiagnostics business in China. Despite this, the company’s CEO has acknowledged the challenges but believes the stock drop is an overreaction.
Current Stock Price and Trading Information
- Current stock price: $90 per share
- Decrease from previous day: $4
- Trading information: subject to change based on market conditions